Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 488

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

Hyperglycemia and Adverse Pregnancy Outcomes: The HAPO Study Cooperative Research Group

·2008·Obstetrical & Gynecological Survey

Abstract

Overt diabetes mellitus during pregnancy carries a significantly increased risk of adverse perinatal outcomes, but whether this is also true of less severe maternal hyperglycemia, or “gestational diabetes,” remains uncertain. The Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study was planned to clarify the risk, if any, associated with less marked maternal glucose intolerance than is associated with overt diabetes. A standard oral glucose tolerance test using a 75-g dose of glucose was carried out at 24–32 weeks’ gestation (target date: 28 weeks) in 25,505 pregnant women aged 18 and over at 15 centers in nine countries. Patient information remained blinded for 23,316 women whose fasting plasma glucose level did not exceed 105 mg/dL (5.8 mmol/L), and whose 2-hour plasma glucose was 200 mg/dL (11.1 mmol/L) or less. For women with blinded data, adjusted odds ratios (ORs) were calculated for adverse pregnancy outcomes associated with a 1-SD (standard deviation) increase in fasting plasma glucose (6.9 mg/dL or 0.4 mmol/L); a 1-SD increase in the 1-hour plasma glucose (30.9 mg/dL or 1.7 mmol/L); and a 1-SD increase in the 2-hour plasma glucose (23.5 mg/dL or 1.3 mmol/L). The respective ORs for birth weight above the 90th percentile were 1.38 (95% confidence interval, 1.32–1.44), 1.46 (1.39–1.53), and 1.38 (1.32–1.44). For a cord-blood serum C-peptide level above the 90th percentile the figures were 1.55 (1.47–1.64), 1.46 (1.38–1.54), and 1.37 (1.30–1.44). The ORs for primary cesarean delivery were 1.11 (1.06–1.15), 1.10 (1.06–1.15), and 1.08 (1.03–1.12); and for neonatal hypoglycemia, 1.08 (0.98–1.19), 1.13 (1.03–1.26), and 1.10 (1.00–1.12). No obvious thresholds were found at which risk levels increased. Nonadjusted analyses disclosed no increase in the risk of perinatal death with increasing glucose levels. Significant associations, although weaker, were found for secondary outcomes including premature delivery, shoulder dystocia or birth injury, the need for intensive neonatal care, hyperbilirubinemia, and preeclampsia. Finding significant associations between increased but not diabetic maternal blood glucose levels and several adverse pregnancy outcomes suggests the need to reconsider currently used criteria for diagnosing and treating hyperglycemia in pregnant women.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/ogx.0b013e318187b7a2

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 20 references

Cited by

See all 488

Metadata

Venue
Obstetrical & Gynecological Survey
Published
2008-10
Volume
63
Issue
10
Pages
615-616
ISSN
0029-7828 (ISSN-L)
OpenAlex
W2182058560
Cited by
488
References
20
FWCI
34.79
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Hyperglycemia and Adverse Pregnancy Outcomes: The HAPO Study Cooperative Research Group. https://app.cochat.ai/papers/10.1097/ogx.0b013e318187b7a2
The paper
Hyperglycemia and Adverse Pregnancy Outcomes: The HAPO Study Cooperative Research Group. (2008). Obstetrical & Gynecological Survey. https://doi.org/10.1097/ogx.0b013e318187b7a2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.